1-4 of 4
Priya Choudhry, PhD
Close
Sort by
Journal Articles

Phase II Study of Daratumumab in Combination with Azacitidine and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Daratumumab: Darazadex

Swetha Kambhampati, MD, Sandy W. Wong, MD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Priya Choudhry, PhD, William Karlon, MD PhD, Arun P. Wiita, MD PhD, Nina Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-138869
Published: 2020
Journal Articles

Identifying Factors in Multiple Myeloma Controlling Response to B-Cell Maturation Antigen (BCMA)-Targeted Immunotherapy Using CRISPR-Based Functional Genomics

Poornima Ramkumar, PhD, Jaime Leong, B.S., Meghan Seyler, B.S., Stratton J Georgoulis, Axel Hyrenius Wittsten, PhD, Priya Choudhry, PhD, Kole Roybal, PhD, Arun P Wiita, MD PhD, Martin Kampmann, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1926.
https://doi.org/10.1182/blood-2018-99-115368
Published: 2018
Journal Articles

DNA Methyltransferase Inhibitors Increase Expression of CD38 and Enhance Daratumumab Efficacy in Multiple Myeloma

Priya Choudhry, PhD, Margarette C. Mariano, MS, Arun P Wiita, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5618.
https://doi.org/10.1182/blood-2018-99-114206
Published: 2018
Journal Articles

T Cell Engagement without Cytokine Storm: A Novel Bcma x CD3 Antibody Killing Myeloma Cells with Minimal Cytokine Secretion

Ben Buelow, MD PhD, Duy Pham, Priya Choudhry, PhD, Kevin Dang, Payal Pratap, Starlynn Clarke, PhD, Katherine Harris, PhD, Brett Jorgensen, PhD, Shelley Force Aldred, Ute Schellenberger, PhD, Nina Shah, MD, Nathan Trinklein, PhD, Arun P. Wiita, MD PhD, Suhasini Iyer, PhD, Wim Van Schooten, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 501.
https://doi.org/10.1182/blood.V130.Suppl_1.501.501
Published: 2017